Spravato, a depression treatment derived from club drug ketamine, was looking like a dud. Its recent success now shows a path forward for psychedelic-based medicines.
Related Posts
Lithium Americas Says GM Boosts Investment in Lithium Project
Canada’s Lithium Americas said General Motors will boost investment in the miner’s Thacker Pass project, which produces the critical ingredient for electric-vehicle batteries.
Railroads Love ‘Monster’ Trains. Texans Don’t.
Freight trains are getting longer—some of them 3 miles or more—and that is making life unpleasant in places like Pleasantville, Texas.
Skincare Company Galderma Sees Opportunity in ‘Ozempic Face’
Speedy weight loss from drugs used to fight obesity and diabetes has left some users looking gaunt and aged. The boss of Swiss skincare group […]